MBX Biosciences, Inc. Common Stock (NASDAQ: MBX) last traded at $52.02, down 2.29% on the session. The quote above updates while this page is open; the figures below are drawn from MBX Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
MBX Biosciences, Inc. Common Stock trades on NASDAQ under the ticker MBX. Its market capitalisation is $2.51 billion.
Valuation measures for MBX Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.51B |
|---|---|
| Enterprise value | $2.48B |
| Price / book | 6.12 |
| Beta | 1.04 |
Trailing-twelve-month figures tagged in MBX Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$104.32M |
| EPS (TTM) | -$2.37 |
|---|
| Return on equity | -25.47% |
|---|
| Cash | $54.12M |
|---|
Range and volume for MBX over the past 52 weeks.
| 52-week high | $72.64 |
|---|---|
| 52-week low | $12.94 |
| Volume | 991.6K |
| Average volume | 536.3K |
| Previous close | $53.24 |
Invest a chosen dollar amount in MBX Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MBX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.